|
|
 |
|
Viewing report
|
|
|
|
AKELA Pharma Inc. (AKLPF) - Financial and Strategic Analysis Review
GlobalData, Aug 2010, Pages: 30
Akela Pharma Inc., (Akela) is an integrated product development company focused on developing drug delivery technologies and therapeutics for the pain market. It also provides research and development services including specialty drug manufacturing, product development & testing, analytical method development and patent litigation support services. Taifuno is the company’s Inhalation Drug Delivery Platform. The company's lead product, Fentanyl TAIFUN is under development is for the treatment of breakthrough cancer pain. It is a fast-acting fentanyl formulation, delivered using the company’s approved TAIFUN dry powder inhaler platform.
AKELA Pharma Inc. Key Recent Developments
Feb 04, 2010 Akela Announces Outcomes Of Legal Cases
Nov 16, 2009 AKELA Pharma Reports Total Revenues Of $3.1 Million In Q3 2009
Nov 04, 2009 AKELA Adds Spray Drying Technology To Bioavailability Enhancement Solutions
Nov 04, 2009 Akela Enhances Its Manufacturing Capabilities With Spray Drying Technology
Aug 17, 2009 AKELA Pharma Reports Total Revenues Of $4 Million In Q2 2009
This comprehensive SWOT profile of AKELA Pharma Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including,
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note-: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
-The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key
competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered
in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and
efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
AKELA Pharma Inc. (AKLPF) - Financial and Strategic SWOT Analysis Review
AKELA Pharma Inc. - Product Pipeline Review - H2 2011
AKELA Pharma Inc. - Product Pipeline Review - Q1 2011
NovaDel Pharma, Inc. (NVDL) - Financial and Strategic SWOT Analysis Review
Nutra Pharma Corporation (NPHC) - Financial and Strategic SWOT Analysis Review
AspenBio Pharma, Inc. (APPYD) - Financial and Strategic SWOT Analysis Review
Pain Therapeutics, Inc. (PTIE) - Financial and Strategic SWOT Analysis Review
Antares Pharma, Inc. (AIS) - Financial and Strategic SWOT Analysis Review
Array BioPharma Inc. (ARRY) - Financial and Strategic SWOT Analysis Review
Orexo AB (ORX) - Financial and Strategic SWOT Analysis Review
|
|
|
|
